Citadel Advisors
ARVN icon

Citadel Advisors’s Arvinas ARVN Stock Holding History

Citadel Advisors’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$372K Sell
35,100
-48,700
-58% -$603K ﹤0.01% 9974
2025
Q4 		$994K Sell
83,800
-28,900
-26% -$316K ﹤0.01% 7404
2025
Q3 		$960K Sell
112,700
-50,500
-31% -$383K ﹤0.01% 7617
2025
Q2 		$1.2M Buy
163,200
+39,900
+32% +$294K ﹤0.01% 6695
2025
Q1 		$866K Buy
123,300
+104,200
+546% +$1.63M ﹤0.01% 7284
2024
Q4 		$366K Sell
19,100
-7,600
-28% -$185K ﹤0.01% 9254
2024
Q3 		$658K Sell
26,700
-3,600
-12% -$94K ﹤0.01% 7680
2024
Q2 		$807K Sell
30,300
-5,400
-15% -$172K ﹤0.01% 7027
2024
Q1 		$1.47M Buy
35,700
+7,200
+25% +$315K ﹤0.01% 6122
2023
Q4 		$1.17M Buy
28,500
+23,200
+438% +$542K ﹤0.01% 6365
2023
Q3 		$104K Sell
5,300
-18,600
-78% -$456K ﹤0.01% 10846
2023
Q2 		$593K Buy
23,900
+8,100
+51% +$208K ﹤0.01% 7562
2023
Q1 		$432K Sell
15,800
-2,800
-15% -$88.4K ﹤0.01% 8605
2022
Q4 		$636K Sell
18,600
-28,600
-61% -$1.2M ﹤0.01% 7748
2022
Q3 		$2.1M Buy
47,200
+8,300
+21% +$403K ﹤0.01% 5496
2022
Q2 		$1.64M Buy
38,900
+4,000
+11% +$201K ﹤0.01% 5965
2022
Q1 		$2.35M Sell
34,900
-7,400
-17% -$504K ﹤0.01% 5733
2021
Q4 		$3.48M Buy
42,300
+25,900
+158% +$2.11M ﹤0.01% 5044
2021
Q3 		$1.35M Sell
16,400
-29,200
-64% -$2.58M ﹤0.01% 7375
2021
Q2 		$3.51M Sell
45,600
-18,000
-28% -$1.25M ﹤0.01% 5239
2021
Q1 		$4.2M Buy
63,600
+34,700
+120% +$2.65M ﹤0.01% 4657
2020
Q4 		$2.45M Buy
+28,900
New +$997K ﹤0.01% 4926
2020
Q3 		– Sell
-20,500
Closed -$688K – 10039
2020
Q2 		$688K Buy
20,500
+11,700
+133% +$497K ﹤0.01% 6502
2020
Q1 		$355K Buy
+8,800
New +$412K ﹤0.01% 7029

Other funds holding ARVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors's ARVN Position: Q1 2026 in Review

Citadel Advisors increased its Arvinas (ARVN) stake by 186% in Q1 2026, buying an estimated $9.5M and bringing the position to 1,180,988 shares worth $12.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2930.

Citadel Advisors first reported a position in ARVN in Q3 2018 and has held it in 28 quarters since. The position peaked at $99.3M in Q4 2023. 206 funds tracked by Wall St. Rank hold ARVN as of Q1 2026.

  • Citadel Advisors held 1,180,988 shares of Arvinas worth $12.5M as of Q1 2026.
  • Citadel Advisors bought 767,342 Arvinas shares in Q1 2026, an estimated $9.5M.
  • Arvinas made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2930 holding.
  • Citadel Advisors first reported a position in Arvinas in Q3 2018 and has held it in 28 quarters since.
  • Citadel Advisors's Arvinas position peaked at $99.3M in Q4 2023.
  • 206 funds tracked by Wall St. Rank held Arvinas as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.